Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- RHY.AU
- Price
- 0.09
- Stock movement down
- -0.00 (-2.30%)
- Company name
- Rhythm Biosciences Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 24.11M
- Ent value
- 24.05M
- Price/Sales
- 5.37
- Price/Book
- 27.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 20.31%
- 1 year return
- -26.09%
- 3 year return
- -62.09%
- 5 year return
- -4.14%
- 10 year return
- -
Last updated: 2025-01-04
DIVIDENDS
RHY.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.37 |
| Price to Book | 27.80 |
| EV to Sales | 5.36 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 283.60M |
| EPS (TTM) | -0.05 |
| FCF per share (TTM) | -0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.49M |
| Gross profit (TTM) | 3.08M |
| Operating income (TTM) | -14.74M |
| Net income (TTM) | -11.39M |
| EPS (TTM) | -0.05 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 68.58% |
| Operating margin (TTM) | -328.62% |
| Profit margin (TTM) | -253.99% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 709.50K |
| Net receivables | 37.20K |
| Total current assets | 886.67K |
| Goodwill | 0.00 |
| Intangible assets | 354.10K |
| Property, plant and equipment | 621.40K |
| Total assets | 1.52M |
| Accounts payable | 211.61K |
| Short/Current long term debt | 163.82K |
| Total current liabilities | 561.84K |
| Total liabilities | 651.54K |
| Shareholder's equity | 867.17K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -13.87M |
| Capital expenditures (TTM) | 148.22K |
| Free cash flow (TTM) | -14.02M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -1314.04% |
| Return on Assets | -750.30% |
| Return on Invested Capital | -1205.15% |
| Cash Return on Invested Capital | -1482.80% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.09 |
| Daily high | 0.09 |
| Daily low | 0.08 |
| Daily Volume | 391K |
| All-time high | 2.00 |
| 1y analyst estimate | - |
| Beta | 2.42 |
| EPS (TTM) | -0.05 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 26 Feb 2025 |
Downside potential
Loading...
Downside potential data
| RHY.AU | S&P500 | |
| Current price drop from All-time high | -95.74% | -2.61% |
| Highest price drop | -97.64% | -56.47% |
| Date of highest drop | 2 Aug 2024 | 9 Mar 2009 |
| Avg drop from high | -54.14% | -11.12% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 798 days | 1805 days |
COMPANY DETAILS
Marketcap
24.11M
Marketcap category
Small-cap
Description
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found